Sensitive determination of methotrexate in plasma of children with acute leukemia using double-solvent supramolecular systemas a novel extractant for dispersive liquid-liquid microextraction

A configuration for cooling assisted organic solvent coated thin film microextraction after dispersive liquid-liquid microextraction method: A microextraction method for ultra-trace analyzing of volatile sample

A combination of the dispersive liquid-liquid microextraction (DLLME) method based on the total vaporization procedure and cooling-assisted organic solvent-coated thin film microextraction (TFME) was applied for extracting chlorpyrifos (as the model compound). Based on the high thermal conductivity, a nickel foam thin film with the dimensions of 5.0 mm × 5.0 mm was used as a substrate for holding the organic solvent. Supporting thin film by organic solvent increases the thickness and contact area of the film relative to TFME or single drop microextraction (SDME) alone, resulting in a dramatic increase in the extraction efficiency. To protect the organic solvent and enhance the analyte distribution coefficient between the film and the vapor phase, a cooling system was applied. The proposed design was effective due to condensing the target analyte only on the uniform cooled thin film and not on the other regions in the extraction chamber. A corona discharge ionization source-ion mobility spectrometer was employed to identify the analyte. After optimizing the effective parameters, the limits of quantification (S/N = 10) and detection (S/N = 3) were calculated 0.1 and 0.03 μg L-1, respectively, and the dynamic range was measured between 0.1 and 7.0 μg L-1, with a determination coefficient of 0.9997. For three concentration levels of 0.1, 3.0, and 7.0 μg L-1, the relative standard deviations (n = 3) as the repeatability index were to be 6 %, 5 %, and 4 % for intra-day and 9 %, 6 %, and 5 % for inter-day, respectively. The enrichment factor was also calculated to be 3630 for the analyte concentration of 1.0 μg L-1. Well water, potato, and agricultural wastewater were analyzed as the real samples and the relative recovery values were measured between 92 % and 99 %. The accuracy of the proposed technique was validated by the European Standards EN 12393 method. In this approach, two steps of analyte extraction (DLLME and TFME) were used consecutively, resulting in better preconcentration and reduced matrix interference during cleaning-up.

Recent Advances in Dispersive Liquid-Liquid Microextraction for Pharmaceutical Analysis

Sample clean-up and pre-concentration are critical components of pharmaceutical analysis. The dispersive liquid-liquid microextraction (DLLME) technique is widely recognized as the most effective approach for enhancing overall detection sensitivity. While various DLLME modes have been advanced in pharmaceutical analysis, there need to be more discussions on pre-concentration techniques specifically developed for this field. This review presents a comprehensive overview of the different DLLME modes used in pharmaceutical analysis from 2017 to May 2023. The review covers the principles of DLLME, the factors affecting microextraction, the selected applications of different DLLME modes, and their advantages and disadvantages. Additionally, it focuses on multi-extraction strategies employed for pharmaceutical analysis.

Simultaneous Preconcentration of Triazole Fungicide Residues Using In-Situ Coacervative Extraction Based on a Double-Solvent Supramolecular System Prior to High Performance Liquid Chromatographic Analysis

An in situ coacervative extraction (IS-CAE) based on a double-solvent supramolecular system coupled to liquid–liquid microextraction is investigated for extraction and enrichment of triazole fungicides. The formation of a double-solvent supramolecular system was generated by in situ formation and used as an extraction solvent for the coacervative extraction method. No disperser solvent was required. This new double-solvent supramolecular system has a higher extraction ability than any of its components alone. The different factors that could affect the extraction capability were studied and optimized, including the type of double extractant and its volume, salt addition, vortex time, and centrifugation time. Under optimum extraction conditions, this method provides high enrichment factors (EFs) of 73–318 with low limits of detection (LODs) of 0.3–1 μg L⁻¹ and limits of quantitation (LOQs) of 1–3 μg L⁻¹. In addition, the proposed method was prosperously applied for the determination of triazole fungicides in water, fruit juice, and soy milk samples.

Miniaturized green sample preparation approaches for pharmaceutical analysis

The development of green sample preparation procedures is an extremely important research field in which more and more applications are constantly being proposed in different areas, including pharmaceutical analysis. This review article is aimed at providing a general overview of the development of miniaturized green analytical sample preparation procedures in the pharmaceutical analysis field, with special focus on the works published between January 2017 and July 2021. Particular attention has been paid to the application of environmentally friendly solvents and sorbents as well as nanomaterials or high extraction capacity sorbents in which the solvent volumes and reagents amounts are drastically reduced, with their subsequent advantages from the sustainability point of view.

Novel deep eutectic solvent-based liquid phase microextraction for the extraction of estrogenic compounds from environmental samples

Steroid hormones, such as estrone (E1), 17β-estradiol (E2), 17β-ethinylestradiol (EE2) and estriol (E3) are a group of lipophilic active substances, synthesized biologically from cholesterol or chemically. A pH-switchable hydrophobic deep eutectic solvent-based liquid phase microextraction (DES-LPME) technique was established and combined with gas chromatography-mass spectroscopy for the determination of estrogenic compounds in environmental water and wastewater samples. A DES was synthesized using l-menthol as HBA and (1S)-(+)-camphor-10-sulfonic acid (CSA) as HBD, and used as a green extraction solvent. By adjusting the pH of the solution, the unique behavior of the DES in the phase transition and extraction of the desired analytes was investigated. The homogenization process of the mixture is done only by manual shaking in less than 30 seconds and the phase separation is done only by changing the pH and without centrifugation. Some effective parameters on the extraction and derivatization, such as molar ratio of DES components, DES volume, KOH concentration, HCl volume, salt addition, extraction and derivatization time and derivatization prior or after extraction were studied and optimized. Under the optimum conditions, relative standard deviation (RSD) values for intra-day and inter-day of the method based on 7 replicate measurements of 20 ng L⁻¹ of estrogenic compounds and 10 ng L⁻¹ for internal standard in different samples were in the range of 2.2–4.6% and 3.9–5.7%, respectively. The calibration graphs were linear in the range of 0.5–100 ng L⁻¹ and the limits of detection (LODs) were in the range of 0.2–1.0 ng L⁻¹. The relative recoveries of environmental water and wastewater samples which have been spiked with different levels of target compounds were 91.0–108.8%.

A pH-switchable hydrophobic deep eutectic solvent-based liquid phase microextraction (DES-LPME) technique was established and combined with gas chromatography–mass spectroscopy for the determination of estrogenic compounds in environmental samples.

Comparison of LC-MS3 and LC-MRM strategy for quantification of methotrexate in human plasma and its application in therapeutic drug monitoring

A simple, highly selective and high throughput liquid chromatography tandem mass spectrometry cubed (LC/MS³) method was developed and validated for quantification of methotrexate in human plasma. The MS³ detection is a scanning mode of QTrap MS systems or ion trap MS systems. After simple protein precipitation with methanol, methotrexate and methotrexate-d₃ were separated on an Agilent Poroshell 120 SB-C18 column (4.6 × 50 mm, 2.7 µm) using isocratic elution with a mobile phase consisting of 60% 0.1% formic acid in water and 40% 0.1% formic acid in acetonitrile. The flow rate is 0.8 mL/min. MS³ detection in positive ion mode used the MRM³ transitions at m/z 455.2→308.2→175.1 for quantification of methotrexate and m/z 458.2→311.2→175.1 for quantification of methotrexate-d₃. The total run time was only 3 min for each sample. The LC/MS³ assay was linear in the concentration range 10-3000 ng/mL(R² ≥ 0.995) and the intra- and inter-day accuracies were< 3.72% and precisions were< 7.78% at all concentrations. The absolute recoveries (%) and matrix effect (%) for methotrexate in human plasma were between 92.6 and 114.3. The novelty of the presented methodology is the MS³ technique resulting in enhanced selectivity and sensitivity. The application of this LC-MS³ method was successfully completed on 46 human plasma samples and the quantitative results of identical human plasma samples were compared with another LC-MRM based method. Passing-Bablok regression coefficients demonstrated that there is no significant difference between the LC-MS³ method and LC-MRM method. Bland-Altman plots showed a concordant results, supporting the developed LC-MS³ method is a reliable and accurate assay for determination of methotrexate in human plasma. This work is also a proof of concept for using LC-MS³ technique to determination of chemicals in biological samples.